$3.3B deal for Vertex royalities a 'Valley of Death killer' for cystic fibrosis

Patrick Marshal calls a $3.3 billion deal involving future royalties from sales of drugs by Vertex Pharmaceuticals a "Valley of Death killer" for cystic fibrosis...